Searching map area
Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model.
? TBD
scientific article published on 10 March 2009
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Instance of
Scholarly article
Author
Elisabeth de Vries
Robbert H Cool
Afshin Samali
Marjolijn N Lub-de Hooge
Subject
Bioluminescence
Ovarian cancer
xenograft
References
Wikidata